Cargando…

Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities

Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after k...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yin, Sha, Zixin, Peng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560294/
https://www.ncbi.nlm.nih.gov/pubmed/34733559
http://dx.doi.org/10.1155/2021/5497346
_version_ 1784592913420779520
author Li, Yin
Sha, Zixin
Peng, Hui
author_facet Li, Yin
Sha, Zixin
Peng, Hui
author_sort Li, Yin
collection PubMed
description Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases.
format Online
Article
Text
id pubmed-8560294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85602942021-11-02 Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities Li, Yin Sha, Zixin Peng, Hui Int J Nephrol Review Article Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases. Hindawi 2021-10-25 /pmc/articles/PMC8560294/ /pubmed/34733559 http://dx.doi.org/10.1155/2021/5497346 Text en Copyright © 2021 Yin Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Li, Yin
Sha, Zixin
Peng, Hui
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
title Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
title_full Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
title_fullStr Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
title_full_unstemmed Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
title_short Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
title_sort metabolic reprogramming in kidney diseases: evidence and therapeutic opportunities
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560294/
https://www.ncbi.nlm.nih.gov/pubmed/34733559
http://dx.doi.org/10.1155/2021/5497346
work_keys_str_mv AT liyin metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities
AT shazixin metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities
AT penghui metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities